Halliburton CO Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NYSE
Capital Research Global Investors has disclosed a 1.0% ownership stake in Halliburton Co. as of June 30, 2026.
NYSE
Vanguard Capital Management has reported a beneficial ownership of 7.17% in Halliburton Co. common stock as of March 31, 2026.
NYSE
Capital Research Global Investors has reported a 6.7% ownership stake in Halliburton Co. as of March 31, 2026.
NYSE
The Vanguard Group has filed an amended Schedule 13G, reporting 0% beneficial ownership in Halliburton Co. following an internal corporate realignment.
NYSE
Capital Research Global Investors has disclosed a significant 10.3% beneficial ownership stake in Halliburton Co. common stock.
NYSE
SCHEDULE 13G/A: Capital World Investors Reports 2.0% Stake in Halliburton
Capital World Investors has filed an Amendment No. 7 to Schedule 13G, disclosing a 2.0% beneficial ownership stake in Halliburton Co. as of June 30, 2025.
NYSE
Capital Research Global Investors has reported a 5.8% beneficial ownership stake in Halliburton Co., holding over 50 million shares as of June 30, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 8.1% Stake in Halliburton Company
BlackRock, Inc. has filed an amended Schedule 13G, reporting an 8.1% beneficial ownership stake in Halliburton Company's common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: Capital World Investors Discloses 5.5% Stake in Halliburton Co.
Capital World Investors, an investment adviser, has filed an amended Schedule 13G, reporting a 5.5% beneficial ownership stake in Halliburton Co., totaling 47,358,409 shares of common stock as of March 31, 2025.
NYSE
Capital World Investors has reported a beneficial ownership of 11.4% in Halliburton Co., holding over 100 million shares as of December 31, 2024.